Navigation Links
Glaxo Official Memo Urged Scientists to Withhold Information About Paxil's Risks, Trial Hears; Pharmaceutical Industry Today Offers Complete News Coverage

WASHINGTON, Sept. 16 /PRNewswire-USNewswire/ -- Antidepressant drug Paxil, which generated about 2.1% of GlaxoSmithKline's total revenue last year, has been known to cause birth defects, but the world's second-biggest drugmaker hid its risks to pump up profits, a Philadelphia court has heard.

According to available information, Glaxo failed to properly test the drug and urged scientists to conceal Paxil's risks. The Philadelphia trial is the first of more than 600 cases against the London-based company.

Are you satisfied with the way your regular news sources report on these important stories? If not, try Pharmaceutical Industry Today (, for free, to see what you may have been missing.


-- GlaxoSmithKline News -

-- Paxil News -

-- Latest Pharmaceutical News -

For a free trial to Pharmaceutical Industry Today, go to:

About the publisher of Pharmaceutical Industry Today, EIN News,

EIN News was established in 1995, and through the years has built more than 200,000 news feeds organized within over 80 individual news sites. The company has launched the well-known 'Russia News Service' brand and opened Internet news access to China with 'Inside China Today'.

Offering a unique combination of human editing and proprietary scanning software, EIN News won Europe's coveted Momentum Award as the most innovative internet company on the continent. Serving millions of customers, the company distributes its feeds via email or mobile news alerts, online and other channels such as Newsfeed Maker ( and EIN Presswire (

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. By 2018, GlaxoSmithKlines Votrient Will Garner Sales of $640 Million and Will Overtake Pfizers Sutent as the Renal Cell Carcinoma Market Leader
2. GlaxoSmithKline Statement Confirming alli Safety
3. Mahindra Satyam Signs 5 Year SAP Contract with GlaxoSmithKline
4. GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare
5. GlaxoSmithKline Opens $600million Vaccine Plant In Singapore
6. GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
7. GlaxoSmithKline Travel Health: 55 percent of travellers needlessly put themselves at risk from a potentially fatal virus
8. Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
9. GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
10. GlaxoSmithKline Update: Influenza A (H1N1)
11. GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
Post Your Comments:
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: